More compelling evidence on why earlier HIV treatment lengthens survival
Thursday, April 2, 2009 - 13:49
in Health & Medicine
Seattle - A study showing improved survival of starting antiretroviral treatment earlier than current U.S. recommendations is being reported in the April 30 issue of the New England Journal of Medicine. The study found that not starting HIV patients at a CD4 count greater than 500 cells per cubic millimeter increased risk of death by 94 percent.